The FDA may approve birth control pills over-the-counter by the summer, but expressed hesitation due to concerns over women misreading labels on the drug's health concerns.
Milken Institute Chairman Michael Milken joined ‘Mornings with Maria’ to discuss the future of A.I. health care and the Federal Reserve forecasting a ‘mild recession’ later this year.
HRA Pharma requested its contraceptive drug, Opill, generically known as norgestrel, to be made available over-the-counter weeks after the Supreme Court overturned Roe v. Wade. Norgestrel should not be taken by women with a history of breast cancer due to risk of tumors recurring. HRA Pharma said 97% of 206 participants in a study of breast cancer survivors chose not to take the drug after reading its label.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA raises concerns about over-the-counter birth control pillU.S. regulators will vote this week on whether the contraceptive Opill should be made widely available without a prescription.
Lire la suite »
FDA advisory committees meeting to discuss over-the-counter birth controlAdvisory committees of the U.S. Food and Drug Administration are meeting Tuesday and Wednesday to review the first-ever application for an over-the-counter birth control pill.
Lire la suite »
FDA may allow birth control pill without prescription this summer as experts weigh dataHRA Pharma asked the Food and Drug Administration to allow over-the-counter sales of Opill after the Supreme Court said there was no federal right to abortion.
Lire la suite »
FDA Experts to Consider First Over-the-Counter Birth Control PillAs a U.S. Food Drug Administration advisory panel prepares to weigh whether to recommend that a birth control pill be sold over the counter in this country, a coalition of advocates on Monday called attention to the safety and effectiveness of the medication.
Lire la suite »
‘Caught between a rock and a hard place’: FDA considers over-the-counter birth controlThe agency is slated to make a decision on approval of the daily hormonal pill by this summer.
Lire la suite »
Samsung gets FDA clearance for irregular heart rhythm notificationsBut you’ll have to wait until One UI 5 Watch arrives later this year.
Lire la suite »